文献速递心血管腹部泌尿生殖MR

T1与T2(*) mapping在心脏、肝脏及肾脏成像中的临床应用与技术要点

Clinical application and technical considerations of T1 & T2(*) mapping in cardiac, liver, and renal imaging.
PubMed 文献 · Br J Radiol · 2018-07-23

本文概述了基于T1与T2弛豫特性的MRI参数成像在心脏、肝脏和肾脏疾病中的潜在临床应用,涵盖心肌炎、淀粉样变、Anderson-Fabry病、铁沉积、脂肪变、肝硬化、肝铁过载及肾纤维化的定量评估,并讨论了数据采集、分析、质量评估与解读等临床实施所需的技术要点,指出需标准化方法学并验证其对临床决策的影响。

要点

  • T1与T2(*) mapping可像素级定量目标器官的T1、T2(*)及细胞外容积值,用于无创评估纤维化、水肿和浸润性病变。
  • 心脏应用已较成熟,临床价值在心肌炎、淀粉样变、Anderson-Fabry病和铁沉积等疾病中已确立。
  • 肝脏与肾脏的潜在应用包括脂肪变、肝硬化、肝铁过载和肾纤维化的定量评估。

核心结论

  • 基于T1与T2(*) mapping的组织特征描述正从研究工具向临床模态过渡,其临床价值已在心肌炎、淀粉样变、Anderson-Fabry病和铁沉积等疾病中确立,心脏以外的潜在应用包括脂肪变、肝硬化、肝铁过载和肾纤维化的定量评估。

研究设计与样本

  • 本文为综述,检索范围与纳入文献原文未报告。

临床应用与阅片要点

  • 临床实施T1与T2(*) mapping需关注数据采集、数据分析、质量评估和解读等技术要点;实现临床转化需要标准化T1与T2(*) mapping方法学并验证其对临床决策的影响。

局限性

  • 原文指出实现这些技术的临床实施需要标准化T1与T2(*) mapping方法学并验证其对临床决策的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pathological tissue alterations due to disease processes such as fibrosis, edema and infiltrative disease can be non-invasively visualized and quantified by MRI using T1 and T2 relaxation properties. Pixel-wise mapping of T1 and T2 image sequences enable direct quantification of T1, T2(*), and extracellular volume values of the target organ of interest. Tissue characterization based on T1 and T2(*) mapping is currently making the transition from a research tool to a clinical modality, as clinical usefulness has been established for several diseases such as myocarditis, amyloidosis, Anderson-Fabry and iron deposition. Other potential clinical applications besides the heart include, quantification of steatosis, cirrhosis, hepatic siderosis and renal fibrosis. Here, we provide an overview of potential clinical applications of T1 andT2(*) mapping for imaging of cardiac, liver and renal disease. Furthermore, we give an overview of important technical considerations necessary for clinical implementation of quantitative parametric imaging, involving data acquisition, data analysis, quality assessment, and interpretation. In order to achieve clinical implementation of these techniques, standardization of T1 and T2(*) mapping methodology and validation of impact on clinical decision making is needed.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Dekkers IA, Lamb HJ. Clinical application and technical considerations of T1 & T2(*) mapping in cardiac, liver, and renal imaging. Br J Radiol. 2018. PMID: 29975154. doi:10.1259/bjr.20170825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。